I am really looking forward to my trip to San Francisco to attend the Biotech Showcase 2018 convention. This event is well received as a strategic benchmark that is of high importance. The conference will have over 334 billion dollars in capital represented from investors.
The attention this convention gets is huge. Ranging from executives of leading biotech companies to big pharmaceutical companies and big industry experts.
This conference is one of the years most important for investors. People from all over the world will be in attendance. Last year there were over 1,800 companies, over 3,000 people and over 900 investors. That is the sign of a great turnout and the importance of this conference.